6:11 PM
 | 
Sep 06, 2012
 |  BC Extra  |  Company News

Court dismisses KV suit against FDA

A judge in the U.S. District Court for the District of Columbia dismissed a suit from KV Pharmaceutical Co. (OCTQB:KVPHQ) against FDA over the company's preterm birth drug Makena hydroxyprogesterone caproate. KV filed...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >